Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock declines during pre-market. Here’s what’s happening?

NXTP Stock

Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock plunged by 1.77% at last close while the ASLN stock price keeps falling by 6.12% in the pre-market session as well. ASLAN Pharmaceuticals is a clinical-stage immunology biopharmaceutical corporation focusing on discovering novel therapies to improve patients’ lives. ASLAN’s product pipeline includes ASLAN004, a first-in-class monoclonal therapy being formulated […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.